Correction: The Clinical Significance of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome for the Health of Rheumatoid Arthritis Patients

Abstract

This corrects: Dheidan SI, Al-Ghurabi B, Al-Jubouri RH, Madhloom OS. "The Clinical Significance of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome for the Health of Rheumatoid Arthritis Patients." Adv. Life Sci. 2025;12(3):583–588. doi: 10.62940/als.v12i3.2682.

Following publication of this article, it was identified that three references cited in the manuscript were unrelated to the subject matter of the article and/or the context in which they were cited. The incorrect references have been replaced by the authors as follows:

Reference 3, cited in support of a statement on sex-based prevalence differences in RA among Iraqi cohorts:

Original (irrelevant) reference: Taha GI, Talib EQ, Abed FB, Hasan IA. A review of microbial pathogens and diagnostic techniques in children's oral health. Sri Lanka Journal of Child Health, (2024); 53(4): 355–359.

Replaced with: Abdullah WL, Al-Hashimy AF, Al-Ghurabi BH. Role of salivary caspase-1 and gasdermin D in the pathophysiology of rheumatoid arthritis in relation to salivary pH and flow rate of saliva. World Academy of Sciences Journal, (2024); 7(1): 7.

Reference 9, cited in support of a statement on the components of the Disease Activity Score 28:

Original (irrelevant) reference: Talib EQ, Taha GI. Involvement of interleukin-17A (IL-17A) gene polymorphism and interleukin-23 (IL-23) level in the development of peri-implantitis. BDJ Open, (2024); 10(1): 1–8.

Replaced with: Van der Heijde DM, Van't Hof MA, Van Riel PL, Theunisse LA, Lubberts EW, Van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a Disease Activity Score. Annals of the Rheumatic Diseases, (1990); 49: 916–920.

Reference 21, cited in support of a statement on the anti-inflammatory and disease-modifying effects of prednisolone and other glucocorticoids:

Original (irrelevant) reference: Taha GI. Involvement of IL-10 gene polymorphism (rs1800896) and IL-10 level in the development of peri-implantitis. Minerva Dental and Oral Science, (2024); 73(5): 264–271.

Replaced with: Van Everdingen AA, Jacobs JW, Van Reesema DRS, Bijlsma JW. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects: A randomized, double-blind, placebo-controlled clinical trial. Annals of Internal Medicine, (2002); 136: 1–12.

The authors agree to this correction and have confirmed the errors occurred unintentionally. This does not affect the study's findings, conclusions, or overall scientific validity.

The Advancements in Life Sciences Editorial Office apologizes for any inconvenience this may have caused.

Correction Published

08 July 2025: The necessary corrections have been carried out in the Version of Record.